• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025

$5,600.00 – $8,000.00

Clear
$8,000.00
SKU: 25-020KA Unlimited Access Categories: Diagnostics Market Research, in vitro diagnostic, IVD Tags: blood banking, chemistry, Coagulation, COVID-19, Critical Care, cytology, Diagnostics, global market, glucose, Hematology, histology, Immunoassays, in vitro diagnostics, In Vitro Diagnostics (IVD) Market, ivd, molecular Pages: 200
  • Description
  • Table of Contents
  • Latest reports

Description

Updated quarterly (four times a year) to reflect market changes

 

Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape.

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

  • Blood Bank Screening – Immunos
  • Coagulation PT/Routine
  • Critical Care (core lab)
  • General Chemistries
  • Hematology
  • Histology
  • Immunoassays – Micro
  • Immunoassays – Non-Micro
  • Microbiology – ID/AST
  • Molecular – Other
  • Molecular Bloodstream/HAI
  • Molecular HIV & Hepatitis
  • Molecular Respiratory
  • POC Critical Care
  • POC Fecal Occult
  • POC Glucose (all)
  • POC Infectious Disease (all)
  • POC Pregnancy & Fertility
  • Other IVD
  • Other POC

The report captures key market drivers, including international developments, regulatory changes, mergers and acquisitions, and new product launches, providing essential intelligence for industry stakeholders. Unlike fragmented country-specific reports, Kalorama’s 30-Country IVD Market Atlas, 2025 consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence.

Subscribers gain access to the report’s quarterly updates via Kalorama’s Knowledge Center, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.

Table of Contents

Chapter 1: Worldwide IVD Market

IVD Market Demand and Growth

Scope and Methodology

Market Segmentation

Country Atlas Scope

  • Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2024
  • Table 1-2: Global IVD Market by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Figure 1-1: Global IVD Market by Leading Countries, Estimated 2024 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Figure 1-2: Global IVD Market by Leading Countries, Estimated 2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

 

Chapter 2: U.S. IVD Market

United States IVD Market Overview

  • Table 2-1: U.S. IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 2-1: U.S. IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 2-2: U.S. IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in the United States

 

Chapter 3: Germany IVD Market

Germany IVD Market Overview

  • Table 3-1: Germany IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 3-1: Germany IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 3-2: Germany IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Germany

 

Chapter 4: China

China IVD Market Overview

  • Table 4-1: China IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 4-1: China IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 4-2: China IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in China

 

Chapter 5: Japan IVD Market

Japan IVD Market Overview

  • Table 5-1: Japan IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 5-1: Japan IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 5-2: Japan IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Japan

 

Chapter 6: France

France IVD Market Overview

  • Table 6-1: France IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 6-1: France IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 6-2: France IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in France

 

Chapter 7: United Kingdom

United Kingdom IVD Market Overview

  • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 7-1: United Kingdom IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 7-2: United Kingdom IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in the United Kingdom

 

Chapter 8: Italy

Italy IVD Market Overview

  • Table 8-1: Italy IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 8-1: Italy IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 8-2: Italy IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Italy

 

Chapter 9: Canada

Canada IVD Market Overview

  • Table 9-1: Canada IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 9-1: Canada IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 9-2: Canada IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular – Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Canada

 

Chapter 10: Spain

Spain IVD Market Overview

  • Table 10-1: Spain IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 10-1: Spain IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 10-2: Spain IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Spain

 

Chapter 11: Australia

Australia IVD Market Overview

  • Table 11-1: Australia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 11-1: Australia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 11-2: Australia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Australia

 

Chapter 12: Brazil

Brazil IVD Market Overview

  • Table 12-1: Brazil IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 12-1: Brazil IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 12-2: Brazil IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 13: India

India IVD Market Overview

  • Table 13-1: India IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 13-1: India IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 13-2: India IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in India

 

Chapter 14: Russia

Russia IVD Market Overview

  • Table 14-1: Russia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 14-1: Russia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 14-2: Russia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 15: The Netherlands

The Netherlands IVD Market Overview

  • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 15-1: The Netherlands IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 15-2: The Netherlands IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in the Netherlands

 

Chapter 16: Switzerland

Switzerland IVD Market Overview

  • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 16-1: Switzerland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 16-2: Switzerland IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in Switzerland

 

Chapter 17: Poland

Poland IVD Market Overview

  • Table 17-1: Poland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 17-1: Poland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 17-2: Poland IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 18: Turkey

Turkey IVD Market Overview

  • Table 18-1: Turkey IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 18-1: Turkey IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 18-2: Turkey IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 19: Mexico

Mexico IVD Market Overview

  • Table 19-1: Mexico IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 19-1: Mexico IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 19-2: Mexico IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 20: Sweden

Sweden IVD Market Overview

  • Table 20-1: Sweden IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 20-1: Sweden IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 20-2: Sweden IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 21: Belgium

Belgium IVD Market Overview

  • Table 21-1: Belgium IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 21-1: Belgium IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 21-2: Belgium IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 22: Austria

Austria IVD Market Overview

  • Table 22-1: Austria IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 22-1: Austria IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 22-2: Austria IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 23: Saudi Arabia

Saudi Arabia IVD Market Overview

  • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 23-2: Saudi Arabia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 24: South Korea

South Korea IVD Market Overview

  • Table 24-1: South Korea IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 24-1: South Korea IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 24-2: South Korea IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in South Korea

 

Chapter 25: Egypt

Egypt IVD Market Overview

  • Table 25-1: Egypt IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 25-1: Egypt IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 25-2: Egypt IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 26: Romania

Romania IVD Market Overview

  • Table 26-1: Romania IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 26-1: Romania IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 26-2: Romania IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 27: South Africa

South Africa IVD Market Overview

  • Table 27-1: South Africa IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 27-1: South Africa IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 27-2: South Africa IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 28: Indonesia

Indonesia IVD Market Overview

  • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 28-1: Indonesia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 28-2: Indonesia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 29: Chile

Chile IVD Market Overview

  • Table 29-1: Chile IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 29-1: Chile IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 29-2: Chile IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Chapter 30: United Arab Emirates

United Arab Emirates IVD Overview

  • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 30-2: United Arab Emirates IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

IVD News in the United Arab Emirates

 

Chapter 31: Vietnam

Vietnam IVD Market Overview

  • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 31-1: Vietnam IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 31-2: Vietnam IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular – Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

 

Appendix: 30-Country IVD Segment Totals

  • Table A-1: Blood Bank Screening (Immunos), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-2: Coagulation PT/INR, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-3: Critical Care (core lab), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-4: General Chemistries, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-5: Hematology, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-6: Histology, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-7: Immunoassays (Micro), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-8: Immunoassays (Non-Micro), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-9: Microbiology (ID/AST), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-10: Molecular Bloodstream/HAI, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-11: Molecular HIV & Hepatitis, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-12: Molecular Respiratory, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-13: Molecular (Other), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-14: POC Critical Care , Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-15: POC Fecal Occult, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-16: POC Glucose (all), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-17: POC Infectious Disease (all), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-18: POC Pregnancy & Fertility, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-19: Other IVD, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Table A-20: Other POC, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024-2029 Molecular Diagnostics Quarterly Datastream, 2025
Scroll to top